- Home
- / Ind-Swift Laboratories
Ind-Swift Laboratories
Revenue
₹6.4 B
FY, 2026
Ind-Swift Laboratories Summary
Company Summary
- Overview
- Ind-Swift Laboratories (also known as Ind-Swift Group) is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), custom chemicals, and impurities. The company also provides contract research and manufacturing services.
- Type
- Public
- Status
- Active
- Founded
- 1986
- HQ
- Chandigarh, IN | view all locations
- Cybersecurity rating
- ESG rating
- Sectors
Table of Contents
Key People
Rishav Mehta, Executive Director
Sahil Munjal, President- Operations
Vikas Narendra, President- US Operations
LocationsView all
3 locations detected
Chandigarh, CH HQ
India
SCO 850, Shivalik Enclave, NAC Manimajra, Sector 13
Dover, DE
United States
3500 South Dupont Highway
Chandigarh, CH
India
E-5, Industrial Area, Phase-II
Ind-Swift Laboratories Financials
Summary Financials
- Revenue (FY, 2026)
- ₹6.4B
- Gross profit (FY, 2026)
- ₹4.1B
- Net income (FY, 2026)
- ₹413.2M
- Cash (FY, 2026)
- ₹4.3B
- EBIT (FY, 2026)
- ₹504.5M